Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Blood Group Typing market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Blood Group Typing market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
The Blood Group Typing market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Blood Group Typing products across developed and developing countries of the world.
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Blood Group Typing products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Blood Group Typing market.
To learn more about this report
Increasing research and development spending on Blood Group Typing development has been the leading industry trend of Blood Group Typing market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
To learn more about this report
| Report Attributes | Details |
| The market size value in 2021 | USD XX.XX Million |
| CAGR (2021 - 2028) | XX.XX % |
| The Revenue forecast in 2028 | USD XX.XX Million |
| Base year for estimation | 2021 |
| Historical data | 2018-2019 |
| Forecast period | 2022-2028 |
| Quantitative units |
|
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook | PCR-based and Microarray Techniques, Assay-based Techniques, Massively Parallel Sequencing Techniques, Other Techniques |
| By Application Outlook | Antibody Screening, HLA Typing, Cross-matching Tests, ABO Blood Tests, Antigen Typing |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled | Grifols, S.A.; Merck KGaA; Bio-Rad Laboratories, Inc.; Immucor, Inc.; Novacyt Group; Danaher Corporation; Agena Bioscience, Inc.; Ortho Clinical Diagnostics; and Quotient, Ltd. |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Information Procurement
1.2.1 Purchased Database
1.2.2 Eternity’s Internal Database
1.2.3 Secondary sources & third-party perspectives
1.2.4 Primary Research
1.3 Information analysis
1.4 Market formulation & data visualization
1.5 Data validation & publishing
2 Executive Summary
3 Blood Group Typing Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.2 Market Restraints
3.1.3 Market Challenge Analysis
3.1.4 Market Opportunities
3.1.5 Micro & Macro Indicator
3.2 Impact of COVID-19 Pandemic on Global Blood Group Typing Market
3.2.1 Overview of Changing Landscape
3.2.2 Pre-covid & Post-Covid Market Analysis
3.3 Market Attractiveness Analysis
3.4 Regulatory Scenario
3.5 Industry Trend Analysis- Historic and Future Trend Assessment
3.6 Merger & Acquisition
3.7 New System Launch/Approvals
3.8 Market Analysis Tools
3.8.1 Porter’s Five Forces
3.8.2 PEST Analysis
3.8.3 Value Chain Analysis
3.9 Key Company Ranking Analysis, 2020
4 Global Blood Group Typing Market Analysis and Forecast, By Type
4.1 Overview & Definition
4.2 Key Trends
4.3 Global Blood Group Typing Market Value (US$ Mn) Forecast, by Type (2019 – 2028)
4.2.1 PCR-based and Microarray Techniques
4.2.2 Assay-based Techniques
4.2.3 Massively Parallel Sequencing Techniques
4.2.4 Other Techniques
4.4 Type Comparison Matrix
4.5 Global Blood Group Typing Market Attractiveness, By Type
5 Global Blood Group Typing Market Analysis and Forecast, By Application
5.1 Overview & Definition
5.2 Key Trends
5.3 Global Blood Group Typing Market Value (US$ Mn) Forecast, by Application (2019 – 2028)
5.3.1 Antibody Screening
5.3.2 HLA Typing
5.3.3 Cross-matching Tests
5.3.4 ABO Blood Tests
5.3.5 Antigen Typing
5.4 Application Comparison Matrix
5.5 Global Blood Group Typing Market Attractiveness, by Application
6 Global Blood Group Typing Market Analysis and Forecast, By Region
6.1 Overview & Definition
6.2 Key Trends
6.3 Global Blood Group Typing Market Value (US$ Mn) Forecast, by Region (2019 – 2028)
6.4 North America
6.5 Europe
6.6 Asia Pacific
6.7 Latin America
6.8 Middle East & Africa
7 Global Blood Group Typing Market Attractiveness, by Region
8 North America Blood Group Typing Market Analysis and Forecast
8.1 Key Findings
8.2 North America Blood Group Typing Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
8.2.1 PCR-based and Microarray Techniques
8.2.2 Assay-based Techniques
8.2.3 Massively Parallel Sequencing Techniques
8.2.4 Other Techniques
8.3 North America Blood Group Typing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
8.3.1 Antibody Screening
8.3.2 HLA Typing
8.3.3 Cross-matching Tests
8.3.4 ABO Blood Tests
8.3.5 Antigen Typing
8.4 North America Blood Group Typing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
8.4.1 U.S.
8.4.2 Canada
8.4.3 Rest of North America
8.5 North America Blood Group Typing Market Attractiveness Analysis
8.5.1 By Type
8.5.2 By Application
8.5.3 By Country
9 Europe Blood Group Typing Market Analysis and Forecast
9.1 Key Findings
9.2 Europe Blood Group Typing Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
9.2.1 PCR-based and Microarray Techniques
9.2.2 Assay-based Techniques
9.2.3 Massively Parallel Sequencing Techniques
9.2.4 Other Techniques
9.3 Europe Blood Group Typing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
9.3.1 Antibody Screening
9.3.2 HLA Typing
9.3.3 Cross-matching Tests
9.3.4 ABO Blood Tests
9.3.5 Antigen Typing
9.4 Europe Blood Group Typing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
9.4.1 U.K.
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Rest of Europe
9.5 Europe Blood Group Typing Market Attractiveness Analysis
9.5.1 By Type
9.5.2 By Application
9.5.3 By Country
10 Asia Pacific Blood Group Typing Market Analysis and Forecast
10.1 Key Findings
10.2 Asia Pacific Blood Group Typing Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
10.2.1 PCR-based and Microarray Techniques
10.2.2 Assay-based Techniques
10.2.3 Massively Parallel Sequencing Techniques
10.2.4 Other Techniques
10.3 Asia Pacific Blood Group Typing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
10.3.1 Antibody Screening
10.3.2 HLA Typing
10.3.3 Cross-matching Tests
10.3.4 ABO Blood Tests
10.3.5 Antigen Typing
10.4 Asia Pacific Blood Group Typing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Asia Pacific Blood Group Typing Market Attractiveness Analysis
10.5.1 By Type
10.5.2 By Application
10.5.3 By Country
11 Latin America Blood Group Typing Market Analysis and Forecast
11.1 Key Findings
11.2 Latin America Blood Group Typing Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
11.2.1 PCR-based and Microarray Techniques
11.2.2 Assay-based Techniques
11.2.3 Massively Parallel Sequencing Techniques
11.2.4 Other Techniques
11.3 Latin America Blood Group Typing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
11.3.1 Antibody Screening
11.3.2 HLA Typing
11.3.3 Cross-matching Tests
11.3.4 ABO Blood Tests
11.3.5 Antigen Typing
11.4 Latin America Blood Group Typing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
11.4.1 Brazil
11.4.2 Rest of Latin America China
11.5 Latin America Blood Group Typing Market Attractiveness Analysis
11.5.1 By Type
11.5.2 By Application
11.5.3 By Country
12 Middle East & Africa (MEA) Blood Group Typing Market Analysis and Forecast
12.1 Key Findings
12.2 Middle East & Africa (MEA) Blood Group Typing Market Analysis (US$ Mn) and Forecast, By Product Type (2019-2028)
12.2.1 PCR-based and Microarray Techniques
12.2.2 Assay-based Techniques
12.2.3 Massively Parallel Sequencing Techniques
12.2.4 Other Techniques
12.3 Middle East & Africa (MEA) Blood Group Typing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
12.3.1 Antibody Screening
12.3.2 HLA Typing
12.3.3 Cross-matching Tests
12.3.4 ABO Blood Tests
12.3.5 Antigen Typing
12.4 Middle East & Africa (MEA) Blood Group Typing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
12.4.1 GCC Countries
12.4.2 South Africa
12.4.3 Rest of MEA
12.5 Middle East & Africa (MEA) Blood Group Typing Market Attractiveness Analysis
12.5.1 By Type
12.5.2 By Application
12.5.3 By Country
13 Competitive Landscape
13.1 Market Players – Competition Matrix
13.2 Market Share Analysis by Key Players, 2020 (%)
13.3 Company Profiles
13.3.1 Grifols
13.3.1.1 Company Overview
13.3.1.2 Company Snapshot
13.3.1.3 Financial Overview
13.3.1.4 Product Portfolio
13.3.1.5 Key Developments/Strategies
13.3.2 S.A.; Merck KGaA; Bio-Rad Laboratories
13.3.3 Inc.; Immucor
13.3.4 Inc.; Novacyt Group; Danaher Corporation; Agena Bioscience
13.3.5 Inc.; Ortho Clinical Diagnostics; and Quotient
13.3.6 Ltd.
14 Key Takeaways
Choose License Type